NORTHWEST BIOTHERAPEUTICS INC: cashflow_financing
| Value | {"amount": 11733000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-03-31 |
| Status | current |
| Entity | NORTHWEST BIOTHERAPEUTICS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:38:52.834193+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a4c6220d-b928-4aa5-8d75-25219212d58f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001410578-25-001333 · Open the official SEC filing →Retrieved: 2026-08-19T10:38:52.834193+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001072379/cashflow-financing/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a4c6220d-b928-4aa5-8d75-25219212d58f
History
- no predecessors — first report